The North American newborn screening market was estimated to grow at a CAGR of 13.73% over the forecast period of 2019-2027, the market is primarily driven by the compensatory rules & regulations of newborn screening market in the United States along with the presence of many newborn screening centers along with rising hearing disorders in newborn babies in Canada.

NORTH AMERICA NEWBORN SCREENING MARKET FORECAST 2019-2027

North America Newborn Screening Market By Product (new-born Screening Instruments, New-born Screening Reagents & Assay Kits) By Test Type (hearing Screen Test, Critical Congenital Heart Disease (cchd) Test, Dry Blood Spot Test) By Technology (tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, Dna Based Assays, Electrophoresis, Others) By Geography.

Request free sample

The North American newborn screening market was estimated to grow at a CAGR of 13.73% over the forecast period of 2019-2027, the market is primarily driven by the compensatory rules & regulations of newborn screening market in the United States along with the presence of many newborn screening centers along with rising hearing disorders in newborn babies in Canada.

The United States and Canada are significant contributors to the North American newborn screening market. The U.S newborn screening market contributed the highest revenue in 2018 and is expected to continue its successful run throughout the forecasted years.

According to the Centre for Disease Control & Prevention, every baby born in the United States should be medically screened for any abnormalities, which makes new-born screening a law-abiding aspect in the country.

The Canadian market, on the other hand, is expected to grow because of reassuring government policies in the country which are driving the newborn screening market in North America.

For instance, the United States Government has mandated the newborn hearing screening among all the territories and 50 states of the United States since 1996, as per Journal of Early Hearing Detection and Intervention (JEHDI) 2016 research.

Some of the known players in this market include Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • SUPPORTIVE GOVERNMENT POLICIES IN US AND CANADA
        • DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
        • GROWTH IN DRY BLOOD SPOT TEST
        • TECHNIQUES USED IN NEWBORN SCREENING TESTS
    1. MARKET DYNAMICS
      • ETYMOLOGY OF NEWBORN SCREENING
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • INCREASE IN OCCURRENCES OF NEWBORN DISEASES
        • GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
        • BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
        • RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
      • MARKET RESTRAINTS
        • ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
        • SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
      • MARKET OPPORTUNITIES
        • INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
        • NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
        • TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
        • INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
      • MARKET CHALLENGES
        • DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
        • MAINTENANCE OF EQUIPMENT IN HOSPITAL
    1. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    2. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    3. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS
    4. KEY ANALYTICS
      • PORTERS FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF SUPPLIERS
        • BARGAINING POWER OF BUYERS
        • THREAT OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
        • RELIABILITY
        • COST
        • AVAILABILITY
        • TECHNOLOGICAL ADVANCEMENT
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL SUPPLIERS
        • MANUFACTURERS
        • DISTRIBUTORS
        • END-USERS
      • LEGAL, POLICY & REGULATORY FRAMEWORK
    5. NORTH AMERICA
      • UNITED STATES
      • CANADA
    6. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
      • CORPORATE STRATEGIES
        • PRODUCT LAUNCH
      • COMPANY PROFILES
        • SCIEX
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIOTEK INSTRUMENTS INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIO-RAD LABORATORIES INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • CARDINAL HEALTH INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • GE HEALTHCARE LIMITED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • AGILENT TECHNOLOGIES INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MASIMO CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NATUS MEDICAL INCORPORATED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MEDTRONIC PLC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • THERMO FISHER SCIENTIFIC INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NEOGEN LABS PVT. LTD.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • PERKINELMER INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • ZENTECH S.A.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • WATERS CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • TRIVITRON HEALTHCARE
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS

    TABLE LIST

    TABLE 1. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

    TABLE 2. NORTH AMERICA INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS

    TABLE 3. LEADING CAUSE OF INFANT DEATH IN THE UNITED STATES

    TABLE 4. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)

    TABLE 5. NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)

    TABLE 6. NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)

    TABLE 7. NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)

    TABLE 8. OPPORTUNITY MATRIX

    TABLE 9. VENDOR LANDSCAPE

    TABLE 10. REGULATORY FRAMEWORK

    TABLE 11. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027, (IN $ MILLION)

    TABLE 12. LIST OF PRODUCT LAUNCHES

    FIGURE LIST 

    FIGURE 1. NORTH AMERICA NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)

    FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS NORTH AMERICA (0-27 DAYS)

    FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017

    FIGURE 4. NORTH AMERICA NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

    FIGURE 5. NORTH AMERICA NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

    FIGURE 6. NORTH AMERICA NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

    FIGURE 7. NORTH AMERICA NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

    FIGURE 8. NORTH AMERICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

    FIGURE 9. NORTH AMERICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 10. NORTH AMERICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 11. NORTH AMERICA NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 12. NORTH AMERICA NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 13. NORTH AMERICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

    FIGURE 14. NORTH AMERICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

    FIGURE 15. PORTER’S FIVE FORCE ANALYSIS

    FIGURE 16. KEY BUYING IMPACT ANALYSIS

    FIGURE 17. VALUE CHAIN ANALYSIS

    FIGURE 18. NORTH AMERICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

    FIGURE 19. UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 20. CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 21. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

    1. NORTH AMERICA
      • UNITED STATES
      • CANADA
    2. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    3. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    4. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type